������ý����

Forge Nano, a ������ý���� spinout, has announced it will go public through a $1.6 billion blank-check deal, making it the 11th unicorn to spin out of CU ������ý����.

The New York Times, CU ������ý���� Today—A research team of scientists and engineers from the ������ý����, University of Colorado Anschutz Medical Campus and Colorado State University has developed a suite of therapies that prompt aging or damaged joints to repair themselves within weeks, according to animal studies. The Advanced Research Projects Agency for Health (ARPA-H) has advanced the up to $33.5M project to its next phase, and the team has formed Renovare Therapeutics Inc. to move toward commercialization.

The ������ý���� and Techstars, the global startup accelerator and investor, have announced a strategic partnership to expand opportunities for founders and strengthen Colorado’s innovation economy.

Wall Street Journal—The second Trump administration’s “Make America Healthy Again” movement targets vaccines, leading some investors to step back. In biotech investment circles, they are the ultimate contrarians: the venture capitalists who say now is the time to invest in vaccines. VitriVax, a CU ������ý���� spinout, raised more than $17.2 million in Series B financing in October.

Luminate—Empire State Development (ESD) announced the 10 startups chosen for round nine of the New York State-supported Luminate NY accelerator, investment fund and competition—two are CU ������ý���� startups.

PR Newswire—Artimus Robotics, a CU ������ý���� spinout, has announced its newest generation of contracting HASEL actuators that deliver more than twice the mechanical output performance of the previous generation. Artimus, a CU ������ý���� spinout, is now one step closer to commercializing artificial muscles that replicate the performance of mammalian skeletal muscle.

The University of Colorado's Ascent Deep Tech Accelerator has announced its 2026 startup teams. The selected companies span a wide range of disciplines, reflecting the depth and breadth of innovation emerging from CU’s research enterprise.

Destination Startup brings groundbreaking startups built on novel discoveries from top national labs and universities together with investors from throughout North America to catalyze real-world impact. This showcase demonstrates a powerful way to invest in and get funding for innovative research and translate it into impactful business ventures.

DARPA—One research team, led by the ������ý����, formed a startup, AtomTCAD Inc., to bring its high-accuracy thermal modeling tools directly to semiconductor designers. The newly formed company has received funding from the Colorado Office of Economic Development & International Trade, and all four members of AtomTCAD’s research team received fellowships through CU ������ý����’s Ascent Deep Tech Accelerator.

PR Newswire—Think Bioscience, a CU ������ý���� biotechnology spinout focused on unlocking elusive drug targets, has raised $55M in an oversubscribed Series A. Returning investors include AV8 Ventures, CU Innovations and Buff Gold Ventures.